The care platform
that gets paid on your employees’ outcomes
Twin’s Digital Twin Care Platform delivers precision care across your workforce to improve health and lower costs. Each person’s AI Digital Twin learns how their body responds and how they live, so care changes as they do.
Talk to sales
[1] Cleveland Clinic-led randomized trial, NEJM Catalyst, 2025. Individual results may vary.

Twin delivers precision cardiometabolic care across your workforce.
Designed to make metabolic care useful in real life: on a night shift, on the road, between meetings, or at home after a long day.
One care platform. Built around each member. Improving health across conditions.

See how your body responds
Learn how food, activity, sleep, and other daily choices affect your health.

Know what works for you
Your Digital Twin connects the dots and helps you understand what to do next.

Take the next step with support
Your Twin Care Team uses those insights to guide your care as your health changes.
Precision care starts with understanding how each person’s body responds.
Most Care Models
Twin Health
The evidence comes before the economics.
Before you accept an outcomes slide, ask: Compared with what? Twin’s strongest clinical evidence was measured against usual care, and its financial evidence was measured in real-world claims against matched controls.
Clinical source: Cleveland Clinic randomized controlled trial, published in NEJM Catalyst Innovations in Care Delivery (2025), N=150 overall, 12 months. Reversal = A1C <6.5% without glucose-lowering medications except metformin. Individual results vary.
Economic Impact of an AI-Enabled Digital Twin Intervention in Type 2 Diabetes. Presented at ISPOR 2026; May 2026; Philadelphia, PA. Abstract EE221. Value in Health. 2026;29(Suppl 6).
GLP-1s are one tool inside the care model.
GLP-1s can be life-changing for the right member. The buyer risk appears when access becomes the strategy. Twin clinicians use GLP-1s when clinically appropriate, continually reassess how each member is responding, and reduce or discontinue medication when appropriate.
The results speak for themselves.
After GLP-1 discontinuation, members on Twin experience:
The goal is not medication elimination at any cost. The goal is better cardiometabolic health, with medication use adjusted to what is clinically right for each member.

Paid on outcomes,
not utilization.
The strongest risk-transfer question is simple: If the outcome is missed, does the vendor still get paid?
Twin’s pricing model links payment to measurable member outcomes rather than charging for access or participation. A fee is earned only when milestones are achieved.
A stronger care model should not create operational chaos.
A typical employer implementation is approximately 90 days, with timing varying by client complexity, data requirements, and contracting dependencies.
Trusted by leading organizations



.avif)




Frequently asked
questions

Discover what Twin can do for your workforce. It only takes five minutes.
Talk with our team about your population health goals and potential savings.